3M Co. (NYSE:MMM) 3M Technologies: scientists and researchers are exploring a new world at the nanometer level, where materials exhibit unique physical, chemical and biological properties. These unusual properties are already being exploited in our hard coatings, dental restoratives and brightness-enhancing optical films (used in LCD displays). Many 3M technology platforms, including adhesives and pharmaceuticals, are being influenced by the emergence of nano-sized particles.
ABB Ltd. (NYSE:ABB) is a pioneering technology leader that is driving growth in four customer-focused entrepreneurial divisions. As a leader in digitally connected and enabled industrial equipment and systems, ABB is ideally positioned to shape the Energy and Fourth Industrial Revolutions. Nanotech News
Ablynx (Brussels: ABLX.BR) is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening human diseases, including inflammation, thrombosis, oncology and pulmonary disease.
Access Pharmaceuticals, Inc. (OTC:ACCP) is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. Access developed MuGard and ProctiGard and is developing multiple follow-on products. Access also has other advanced drug delivery technologies including CobaCyte™-mediated targeted delivery and CobOral-oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism.
Advanced Nano Technologies (ASX:ANO.AX) (formerly Antaria Limited) is a specialist developer and manufacturer of advanced materials. These materials are used by manufacturers in the personal care, chemical and industrial sectors to add unique or competitive advantages to their end products. Advanced Nano Technologies has expanded from its original research-based foundations to the development of a broader range of advanced materials opportunities. Advanced Nano Technologies's core skills now include the development, scaling-up, manufacturing and marketing of innovative products based on a range of proprietary advanced material technologies and manufacturing processes. To date, Advanced Nano Technologies's commercialised products include metal oxide powders and dispersions of zinc oxide and aluminium oxide.
Agilent Technologies Inc. ( NYSE:A) is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in our solutions. Nano Products, Applications, Part & Articles
Alexium International Group (ASX:AJX.AX) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium's fire retardant chemical treatments are currently marketed for different fabric markets under the Alexiflam™, Ascalon™, Nycolon™, Nuvalon™, and Polytron™, Omnitron™ and Bactron™ trademarks.
American Aires Inc. (CSE: WIFI) is an Ontario based nano-technology company that is focused on the research, development and implementation of innovative technology solutions to allow consumers to safely engage with electronic products of the 21st century. The Company is currently engaged in the business of production, distribution and sales of products intended to protect persons from the harmful effects of electromagnetic emissions, which is produced from electronic devices such as cell phones, Wi-Fi routers, tablets and electronic cars to name a few. The Company has developed a technology that restructures and transforms electromagnetic field haze into a more biologically-compatible form to reduce the harmful effects of electromagnetic radiation. The Company's current principal products are the Aires Shield Pro, Aires Defender Pro and Aires Guardian.
American Premium Water Corporation (OTC:HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company's portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com), Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) and plant + body essentials (www.plantbodyessentials.com). American Premium Water strives in providing only the highest quality CBD sources for its products, with quality control being one of our first and foremost focuses. The Company aims for this standard not only for compliance reasons, but also to provide our customers the highest quality product possible.
AMETEK Inc. (NYSE:AME) is a leading global manufacturer of electronic instruments and electro-mechanical devices with annual sales of approximately $4.0 billion. AMETEK's Corporate Growth Plan is based on Four Key Strategies: Operational Excellence, Strategic Acquisitions, Global & Market Expansion and New Products. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P500 Index. Nanotech Products, News & Business
Applied Materials, Inc. (NasdaqGS:AMAT) is the leader in materials engineering solutions used to produce virtually every new chip and advanced display in the world. Our expertise in modifying materials at atomic levels and on an industrial scale enables customers to transform possibilities into reality. At Applied Materials, our innovations make possible the technology shaping the future. Nanochip Fab Solutions
BASF (OTCPK:BASFY) At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. The approximately 112,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio is organized into five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions and Oil & Gas. BASF is one of the leading companies in the field of chemical nanotechnology. Its research activities also include nanostructured materials and nanoparticles.
Boeing Co (NYSE: BA) engages in the design, development, manufacture, sale, and support of commercial jetliners, military aircraft, satellites, missile defense, human space flight, and launch systems and services worldwide. NanoSat Technologies News
C-Bond Systems (OTC:CBNT) is a Houston-based advanced nanotechnology company and marketer of the patented C-Bond technology, developed in conjunction with Rice University and independently proven to significantly strengthen glass in key automotive and structural applications. The Company's Transportation Solutions Group sells C-Bond NanoShield®, a liquid solution applied directly to automotive windshields, sold through distributors. The Company's Safety Solutions Group sells ballistic-resistant glass solutions directly to private enterprises, schools and government agencies.
Cabot Corp. (NYSE:CBT) is a global performance materials company headquartered in Boston, MA. Cabot's major products are carbon black, fumed silica, inkjet colorants, capacitor materials, aerogel and cesium formate drilling fluids. Cabot Aerogel is a business of Cabot Corporation. Nanotech: Our customers rely on our leadership in carbon and metal oxide materials. Accordingly, we strive to be a world class repository of knowledge in nanoparticle technology. This competency encompasses new particle concepts, synthesis, processing and scale-up, with a strong focus on connecting particle properties to market-driven problems. Our particles are tailor-made to suit the needs of our customers. To accomplish these unique particle designs, we use specially chosen feedstock and sophisticated processes to control particle composition, size, morphology, surface area, porosity, surface energy and chemical functionality. Our leadership in particle technology extends both to strong relationships with academic laboratories across the globe and a prominent position in the regulatory ecosystem for nanomaterials.
Cabot Microelectronics Corp. (NasdaqGS:CCMP) engages in the development, manufacture, and sale of slurries for chemical mechanical planarization process (CMP). Engineered Surface Finishes is a group of Cabot Microelectronics Corporation, the world's leading supplier of chemical mechanical planarization materials and processes for the semiconductor industry. ESF™ research, development and applications teams specialize in developing unprecedented atomic-scale finishes on Metals, Glass, Compound Semiconductors, Ceramics, and other materials. Nanoscale Surface Technology
California Nanotechnologies (TSX:CNO.V) is a world leader in production and research and development of nano-structured components and materials. Metallic, ceramic, MMC, and MMNC materials are used in products from aerospace to sports & recreation industries.
Cavitation Technologies, Inc. (OTC:CVAT) Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, devices and systems, as well as develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algae oil extraction, alcoholic beverage enhancement, and water treatment. As an add-on to its existing neutralization systems, the company's patented Nano Reactor ® allows refiners to significantly reduce both processing costs and environmental impact, while also increasing yield.
Cerulean Pharma Inc. (NasdaqGM:CERU) The Cerulean team is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designed to selectively attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations. Our first platform-generated NDC clinical candidate, CRLX101, is in clinical trials in combination with other cancer treatments, all of which aim to unlock the power of combination therapy. Our second platform-generated NDC clinical candidate, CRLX301, is in a Phase 1/2a clinical trial.
Cool Chips PLC (OTC:COLCF) represent a new development for cooling, refrigeration, and thermal management. One of the first industrial applications of nanotechnology, Cool Chips use thermionic technology to deliver up to a projected 55% of the maximum (Carnot) theoretical efficiency for heat pumps. Conventional refrigerators operate at up to 45% efficiency and current thermoelectric systems (Peltier Effect) operate at 5-8% efficiency.
CVD Equipment Corporation (NasdaqCM:CVV) designs, develops, and manufactures a broad range of chemical vapor deposition, gas control, and other state-of-the-art equipment and process solutions used to develop and manufacture materials and coatings for research and industrial applications. This equipment is used by our customers to research, design, and manufacture these materials or coatings for aerospace engine components, medical implants, semiconductors, solar cells, smart glass, carbon nanotubes, nanowires, LEDs, MEMS, and other applications.
Cypress Semiconductor Corporation (NasdaqGS:CY) is a leader in advanced embedded system solutions for the world's most innovative automotive, industrial, home automation and appliances, consumer electronics and medical products. Cypress's programmable systems-on-chip, general-purpose microcontrollers, analog ICs, wireless and USB-based connectivity solutions and reliable, high-performance memories help engineers design differentiated products and get them to market first. Cypress is committed to providing customers with support and engineering resources that enable innovators and out-of-the-box thinkers to disrupt markets and create new product categories. Nanotech
Dais Analytic Corporation (OTC:DLYT) offers industry-changing nanotechnology applications that address the growth of global water and energy demand. Furthering Dais' proven ability to create eco-friendly heating and cooling products, the company is now innovating cost-effective and energy-efficient methods for both water purification and energy storage solutions.
Donaldson Company Inc. (NYSE:DCI) is a global leader in the filtration industry with approximately 140 sales, manufacturing and distribution locations in 44 countries. Donaldson's innovative filtration technologies improve people's lives, enhance customers' equipment performance and protect the environment. Donaldson Blue® air filters with Ultra-Web® fine fiber technology protect engines by providing better initial and overall efficiency compared to conventional cellulose media. We invented air filters for heavy-duty diesel engines more than 100 years ago and were the first to develop nanofiber air filter media for diesel engines more than 20 years ago. Today, we continue to innovate with Ultra-Web® HD, built specifically to perform better in heavy-dust environments.
Dow Chemical Co (NYSE:DOW) combines the power of science and technology with the Human Element to passionately innovate what is essential to human progress. The Company connects chemistry and innovation with the principles of sustainability to help address many of the world's most challenging problems such as the need for clean water, renewable energy generation and conservation, and increasing agricultural productivity. Nanotech: AQUCAR™ MEM 20 is a Non-Oxidizing Biocide to Reduce Biological Fouling in Reverse Osmosis (RO) Systems for Industrial Water Production and off-line cleaning of RO membranes producing potable and municipal water - controls bacteria and reduces biofouling in various membrane system types (reverse osmosis, ultra-filtration, nano-filtration and microfiltration) used for industrial water processing.
DuPont (NYSE:DD) operates as a science and technology company. It engages in various fields, including biotechnology, electronics, materials science, safety and security, and synthetic fibers. Nanoscale Science & Engineering
Eastman Kodak Company (NYSE:KODK) As the world's foremost imaging innovator, Kodak helps consumers, businesses, and creative professionals unleash the power of pictures and printing to enrich their lives. Nanotech Inks
Eaton Corporation (NYSE:ETN) is a diversified power management company with 2010 sales of $13.7 billion. Eaton is a global technology leader in electrical components and systems for power quality, distribution and control; hydraulics components, systems and services for industrial and mobile equipment; aerospace fuel, hydraulics and pneumatic systems for commercial and military use; and truck and automotive drivetrain and powertrain systems for performance, fuel economy and safety. The NanoView Series from Eaton is a family of miniature rectangular photoelectric sensors designed for optimum value and sensing performance in a wide range of applications.
Enable IPC Corporation (OTC:EIPC) develops and commercializes novel nanostructures in the United States. The company's products include S/Cap asset management RFID tags that are used in aerospace, asset management, cargo identification/tracking, marine, military, pallet identification/tracking, rail, and vehicle identification/tracking applications; RFID Fuse Tags for use in machinery, transportation, and other applications; anodized aluminum oxide nanopore templates for use in nano-filters and nanowire making; ultracapacitors that are used in consumer electronics, industrial, and transportation applications; and SolRayo Potentiostats for use in electrochemistry applications.
Fanuc Corporation (Tokyo: 6954.T) is a Japan-based manufacturing company mainly engaged in the provision of factory automation (FA) machinery. The Company operates in three business divisions. The FA division is engaged in the development, manufacture, sale and maintenance of FA products, such as computer numeric control (CNC) systems and laser products. The Robot division is engaged in the development, manufacture, sale and maintenance of robotic products. The Robot Machine division is engaged in the development, manufacture, sale and maintenance of robodrill, roboshot, robocut and robonano products.
Flexible Solutions International, Inc. (NYSE MKT: FSI) based in Victoria, British Columbia, is an environmental technology company. The Company's NanoChem Solutions Inc. subsidiary specializes in biodegradable, water-soluble products utilizing thermal polyaspartate (TPA) biopolymers. TPA beta-proteins are manufactured from the common biological amino acid, L-aspartic, and have wide usage, including scale inhibitors, detergent ingredients, water treatment, and crop enhancement. The other divisions manufacture energy and water conservation products for drinking water, agriculture, industrial markets, and swimming pools throughout the world. FSI is the developer and manufacturer of WaterSavrTM, the world's first commercially viable water evaporation retardant. WaterSavrTM reduces evaporation by up to 30% on reservoirs, lakes, aqueducts, irrigation canals, ponds, and slow moving rivers. HeatsavrTM, a \"liquid blanket\" evaporation retardant for the commercial swimming pool and spa markets, reduces energy costs by 15% to 40% and can result in reduced indoor pool humidity. The Company's EcosavrTM product targets the residential swimming pool market providing the same savings as HeatsavrTM.
General Electric Co. (NYSE:GE) operates as an infrastructure and financial services company worldwide. Its Power segment offers gas and steam power systems; maintenance, service, and upgrade solutions; distributed power gas engines; water treatment, wastewater treatment, and process system solutions; and nuclear reactors, fuels, and support services. The company's Renewable Energy segment offers wind turbine platforms, and hardware and software; offshore wind turbines; and solutions, products, and services to hydropower industry. Its Oil and Gas segment offers turbomachinery solutions; surface and subsea drilling and production systems, and equipment for floating production platforms; measurement and control products; and compressors, pumps, valves, and natural gas solutions. The companys Energy Management segment offers industrial and grid solutions, and power conversion systems. Its Aviation segment designs and produces commercial and military aircraft engines, integrated digital components, electric power, and mechanical aircraft systems; and offers aftermarket services. The companys Healthcare segment offers diagnostic imaging and clinical systems; products for drug discovery, biopharmaceutical manufacturing, and cellular technologies; and healthcare information technology products. Its Transportation segment offers freight and passenger locomotives, parts, wreck repair, software-enabled solutions, mining equipment and services, marine diesel engines, and stationary power diesel engines and motors, as well as overhaul, repair, and upgrade services. GEs Appliances & Lighting segment sells and services home appliances; and manufactures, sources, and sells lighting solutions. Its Capital segment offers commercial lending and leasing, factoring, energy financial, and aircraft financing and leasing services. GE also designs powder bed-based laser additive manufacturing machines. Nanotech
Graphene 3D Lab Inc. (TSX:GGG.V; OTC: GPHBF) is a world leader in the development, manufacturing and marketing of proprietary composites and coatings based on graphene and other advanced materials. These diverse materials have a wide spectrum of commercial, research and military applications. The Company's wholly owned subsidiary, Graphene Laboratories Inc., currently offers over 100 graphene and related products to a client list comprised of more than 10,000 customers worldwide, including nearly every Fortune 500 tech company and major research university. Some notable clients are: NASA, Ford Motor Co., GE, Apple, Xerox, Samsung, Harvard University, IBM and Stanford University. The Company's suite of products are available online at the company's e-commerce platform Graphene Supermarket (www.graphene-supermarket.com). 3D printing division of the Company offers a portfolio of specialty fused filament fabrication filaments. These materials can be purchased through multiple distribution networks worldwide or directly online at www.blackmagic3D.com. Graphene 3D also holds a new proprietary technology encompassing the preparation and separation of atomic layers of graphene. This technological breakthrough represents a new, energy efficient process to manufacture, sort and classify graphene nanoparticles resulting in the potential for large scale production of high grade graphene at lower costs than exist in today's marketplace. The Graphene 3D facility is located in Calverton, NY and is equipped with material processing
Harris & Harris Group (NasdaqGM:TINY) builds transformative companies from disruptive science. Portfolio: Over the past decade, we have built a portfolio of companies that address today's growth markets and what we believe could be tomorrow's growth opportunities. Many of these companies have applications across multiple industry sectors. Companies include NanoTerra, NanSys
Headwaters Inc. (NYSE:HW) is improving lives through innovative advancements in construction materials through application, design, and purpose. Headwaters is a diversified growth company providing products, technologies and services to the construction materials and building products markets. Through its construction materials and building products businesses, the Company has been able to improve sustainability by transforming underutilized resources into valuable products. HTI - a Headwaters Company: HTI is a world leader of unique catalysts and technologies that provide energy products from low-value feedstocks. Our core technology — the HCAT® Process — is a proprietary and patented method for hydrocracking heavy residual oil. We also offer unique coal-to-liquids conversion technologies and hold patents on a broad range of nanotechnology-based catalysts and catalytic processes. Common technological features are energy efficiency and “green chemistry” which avoids unwanted byproducts and has low environmental impact. HTI's diversified facility includes analytical laboratories, pilot-scale catalyst manufacturing equipment and process modeling capabilities in addition to the pilot plant operating units; all which meet, or exceed, environmental and safety standards.
Hitachi High Technologies America. (OTC:HTHIY) a division of Hitachi, Ltd., is chartered with identifying products and technologies, whether evolutionary or disruptive, that will benefit from our diversity of expertise, market leadership, and established global network. Areas of interest include, but are not limited to: Biotech; Environmental; Cloud-based services; Electronics; Nanotech; New energy; Health; Others.
IBM Nanotech Research (NYSE: IBM) develops and manufactures information technologies, including computer systems, software, networking systems, storage devices, and microelectronics worldwide. More than twenty years ago, two IBM (NYSE: IBM) scientists won the Nobel Prize in Physics for their invention of the Scanning Tunneling Microscope (STM), which opened the world to the possibilities of nanotechnology. Shortly thereafter, in 1989, the letters IBM were spelled using individual atoms by an IBM scientist using a STM. Today, scientists and engineers from IBM Research continue to break new ground in nanotechnology – the science of the very, very small.
Industrial Nanotech Inc. (OTC:INTK) is a global nanoscience solutions and research leader. The Company develops and commercializes new and innovative applications for sustainable manufacturing and buildings which are sold worldwide, including patented thermal insulation and asset protection coatings, which provide energy savings, thermal insulation, corrosion resistance, prevention of CUI, moisture resistance, UV resistance, chemical resistance, and other protective benefits. The coatings are low VOC, water-based, and sustainable.
Infineon Technologies AG (OTC:IFNNY) s a world leader in semiconductor solutions that make life easier, safer and greener. Microelectronics from Infineon is the key to a better future. Products include: Power Board 24V/7.5A + BLDC Motor from Nanotech; 32-Bit Industrial Microcontroller based on ARM® Cortex®-M
ItN Nanovation AG (Xetra:I7N.DE) contributes to solving the global water problem, applying smart, highly efficient water and sewage treatment solutions. Using state-of-the art nano-technology know-how, ItN's CFM Systems® (Ceramic Flat Membranes) micro filtration technology provides unprecedented technical and economical ground water treatment solutions for drinking water applications and complete sewage treatment plants. For each application and process, ItN has developed specific nano-coated filter layers for a targeted filtration process adjusted to the customer's requirements.
KLA-Tencor Corp. (NasdaqGS:KLAC) a leading provider of process control and yield management solutions, partners with customers around the world to develop state-of-the-art inspection and metrology technologies. These technologies serve the semiconductor, data storage, LED and other related nanoelectronics industries. With a portfolio of industry-standard products and a team of world-class engineers and scientists, the company has created superior solutions for its customers for more than 35 years. Headquartered in Milpitas, Calif., KLA-Tencor has dedicated customer operations and service centers around the world.
Kopin Corporation (The NanoSemiconductor Company) (NasdaqGS:KOPN) is a leading developer and provider of innovative wearable technologies and solutions for integration into head-worn computing and display systems to military, industrial and consumer customers. Kopin's technology portfolio includes ultra-small displays, optics, speech enhancement technology, system and hands-free control software, low-power ASICs, and ergonomically designed smart headset reference systems. Kopin's proprietary components and technology are protected by more than 300 global patents and patents pending. Nanotech
Lam Research Corporation (NasdaqGS:LRCX) is a trusted global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's broad portfolio of market-leading deposition, etch, and clean solutions helps customers achieve success on the wafer by enabling device features that are 1,000 times smaller than a grain of sand, resulting in smaller, faster, more powerful, and more power-efficient chips. Through collaboration, continuous innovation, and delivering on commitments, Lam is transforming atomic-scale engineering and enabling its customers to shape the future of technology. Based in Fremont, Calif., Lam Research is a Nasdaq-100 Index® and S&P 500®.
LiqTech International, Inc. (OTC:LIQT) is a clean technology company that for more than a decade has developed and provided state-of-the-art technologies for gas and liquid purification using ceramic silicon carbide filters, particularly highly specialized filters for the control of soot exhaust particles from diesel engines and for liquid filtration. Using nanotechnology, LiqTech develops products using proprietary silicon carbide technology. LiqTech's products are based on unique silicon carbide membranes, which facilitate new applications and improve existing technologies.
Lockheed Martin Corp. (NYSE: LMT) Headquartered in Bethesda, Maryland, Lockheed Martin is a global security and aerospace company that employs approximately 97,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. Nanotech
Luna Innovations Incorporated (NasdaqCM:LUNA) develops high speed optics and high performance fiber optic test products that provide unique capabilities for the aerospace, automotive, energy, defense, and telecommunications industries. Luna develops, manufactures and markets high definition fiber optic sensing products and fiber optic test and measurement instrumentation, and packages optoelectronic semiconductors into HSOR products, custom optoelectronic subsystems (Optoelectronics products) and Terahertz (THz) instrumentation. Luna is organized into two business segments, which work closely together to turn ideas into products: a Technology Development segment and a Products and Licensing segment. Luna's business model is designed to accelerate the process of bringing new and innovative technologies to market. Nanotech
MagForce AG (Frankfurt:MF6.F) together with its subsidiary MagForce USA, Inc. is a leading medical device company in the field of nanomedicine focused on oncology. The Group's proprietary NanoTherm™ therapy enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. Mithril Capital Management, a growth-stage technology fund founded by Ajay Royan and Peter Thiel, along with MagForce AG, are investors and strategic partners in MagForce USA, Inc. NanoTherm™, NanoPlan®, and NanoActivator® are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm™, NanoPlan, and NanoActivator® are trademarks of MagForce AG in selected countries.
Manhattan Scientifics Inc. (OTC:MHTX) is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of transformative technologies in the nano medicine space. The company is presently developing commercial medical prosthetics applications for its ultra-fine grain metals and plans to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, a unit of the Company.
Matinas Biopharma Holdings Inc. (OTC: MTNB) is a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections. The Company's proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead drug candidate is MAT2203, an orally-administered, encochleated formulation of amphotericin B (a broad spectrum fungicidal agent). The Company also intends to file an investigational new drug application (IND) for MAT2501, which is an orally-administered, encochleated formulation of amikacin (a broad spectrum aminoglycoside antibiotic agent) used to treat different types of multidrug-resistant bacterial infections, including nontuberculous mycobacterium infections (NTM) and various multidrug-resistant gram negative bacterial infections. In addition, the Company is exploring development and partnership options for MAT9001, a prescription-only omega-3 fatty acid-based composition under development for hypertriglyceridemia, which has shown superiority versus Vascepa® (icosapent ethyl) in reducing serum triglycerides, Total- and Non-HDL-Cholesterol, apolipoproteins and PCSK9 levels. The Company's lead anti-infective product candidates, MAT2203 and MAT2501, position Matinas BioPharma to become a leader in the safe and effective delivery of anti-infective therapies utilizing its proprietary lipid-crystal nano-particle cochleate formulation technology.
Midatech Pharma Plc (NasdaqCM:MTP) is an international specialty pharmaceutical company focused on oncology and other therapeutic areas with a US commercial operation marketing four cancer care supportive products, and co-promoting two others. Midatech's strategy is to internally develop oncology products and collaborate with partners in other therapy areas, and to drive growth both organically and through strategic acquisitions. The Company's R&D activities are supported by two breakthrough drug delivery technologies: Q-Sphera for sustained release and our proprietary gold nanoparticles.
Nano Dimension (NasdaqCM:NNDM) is a leading additive manufacturing technology company focused on precision 3D printed electronics that is disrupting, reshaping, and defining the future of how functional and connected products are made. With its unique additive manufacturing technologies, Nano Dimension targets the growing demand for electronic devices that require sophisticated features. Demand for circuitry, including PCBs, sensors and antennas - which are the heart of electronic devices - cover a diverse range of industries, including consumer electronics, medical devices, defense, aerospace, automotive, IoT and telecom. These sectors can all benefit greatly from Nano Dimension's products and services for short-run manufacturing and rapid prototyping.
Nano One Materials Corp. (TSX: NNO.V) is developing novel and scalable processing technology for the low-cost production of high performance battery materials used in electric vehicles, energy storage and consumer electronics. The patented technology can be configured for a wide range of nanostructured materials and has the flexibility to shift with emerging and future battery market trends and a diverse range of other growth opportunities. The novel three-stage process uses equipment common to industry and is being engineered for high volume production and rapid commercialization. Nano One's mission is to establish its patented technology as a leading platform for the global production of a new generation of nanostructured composite materials
Nanobiotix (Paris:NANO.PA) is an oncology focused nanomedicine company developing an innovative nanoparticle technology. Nanobiotix is developing new tools for cancer which utilize a physical mode of action at the cellular level of the cancer cell. This disruptive approach may reshape future treatment opportunities. The NanoXray technology comprises three products having the potential to cause a paradigm shift in cancer therapy. Specifically, NanoXray products may overcome the current limitations of standard of care in local therapy. Local treatment (surgery and radiotherapy) plays a seminal role in the potential cure and gives systemic treatment a better chance to increase life expectancy. NanoXray products are developed to selectively increase the efficacy of radiotherapy in the tumor cell.
Nanoco Group (LSE:NANO.L) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications: LCD Display, Lighting, Healthcare, Solar. Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany, and Wah Hong Industrial Corporation of Taiwan. Through these partners and its own production facilities in Runcorn, UK, Nanoco is creating the world's largest manufacturing ecosystem for cadmium-free quantum dots. Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.
Nanoform Finland Plc (FNFI:NANOFH) (SEMM:NANOFS) is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nanoforming services. The Company's patented and scalable Controlled Expansion of Supercritical Solutions (CESS®) technology produces nanoformed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Nanoform's unique technology provides novel opportunities in many value-enhancing drug delivery applications.
NanoLogix, Inc. (OTC: NNLX) is a biotechnology company focused primarily on rapid diagnostics. Its products offer accelerated detection and identification of microorganisms. In addition to medical, National Defense, and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing. Patents granted to NanoLogix can be used in the areas of applied microbiology, soil microbiology and bioremediation, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity.
Nanometrics Inc.(NasdaqGS:NANO) is a leading provider of advanced, high-performance process control metrology and inspection systems used primarily in the fabrication of semiconductors and other solid-state devices, including sensors, optoelectronic devices, high-brightness LEDs, discretes and data storage components. Nanometrics' automated and integrated metrology systems measure critical dimensions, device structures, topography and various thin film properties, including three-dimensional features and film thickness, as well as optical, electrical and material properties. The company's process control solutions are deployed throughout the fabrication process, from front-end-of-line substrate manufacturing, to high-volume production of semiconductors and other devices, to advanced three-dimensional wafer-level packaging applications. Nanometrics' systems enable advanced process control for device manufacturers, providing improved device yield at reduced manufacturing cycle time, supporting the accelerated product life cycles in the semiconductor and other advanced device markets. The company maintains its headquarters in Milpitas, California, with sales and service offices worldwide.
Nanophase Technologies (NasdaqGM:NANX) is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2008 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media.
NanoSphere Health Sciences Inc. (CSE:NSHS) is a biotechnology firm specializing in the creation of a NanoSphere Delivery System™ (NDS) for the supplement, nutraceutical, over-the-counter pharmaceutical industries, and beyond. Its patent-pending NanoSphere Delivery System and industry-first line of bioavailable NanoSphere Gels, represent a significant milestone and one of the most important developments for advancing the non-invasive delivery of biological agents in over 25 years. As an innovative biotechnology company, we are developing a robust and growing portfolio of novel product candidates generated by our patent-pending NanoSphere Delivery System. We address multiple areas including dietary supplements, pharmaceutical and OTC medications, cannabinoids, skin care, animal health, etc.
Nanosonics (ASX:NAN.AX) is engaged in the research, development, and commercialization of infection control and decontamination products, and related technologies. The company also manufactures and distributes trophon EPR ultrasound probe disinfector, and its associated consumables and accessories for use in the treatment of healthcare-acquired infections. It has operations primarily in North America, Europe, Australia, and New Zealand.
Nanosphere Inc. (NasdaqCM:NSPH) is enhancing medicine through targeted molecular diagnostics that result in earlier disease detection, optimal patient treatment and improved healthcare economics. The Company's versatile technology platform, the Verigene® System, enables clinicians to rapidly detect the most complex, costly and deadly infectious diseases through a low cost and simple-to-use multiplexed diagnostic test. The combination of this innovative technology and Nanosphere's customer-driven solutions keeps commitment to the patient at the forefront of its business.
Nanotech Security Corp. (TSX:NTS.V) has been a leading innovator in the design and production of advanced banknote and commercial branding authentication products. Nanotech's KolourOptik® and Plasmogram™ products are nanotechnology based optical imaging product platforms originally inspired by the unique optical properties of the iridescent wings of the Blue Morpho butterfly. Our nano-optical products produce intense, high definition optically-variable images and colour-shift optical thin films. Activated by a simple tilt or rotation, with higher resolutions than the best LED-displays, they are ideal for authentication of currency, passports, and identification cards in addition to distinguishing branded goods from counterfeits.
NanoVibronix Inc. (OTC: NAOV) is a medical device company headquartered in Elmsford, NY with research and development in Nesher, Israel, that is focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave technology. The company's groundbreaking technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications. The devices accelerate wound healing and provide pain relief. The devices can also be administered at home, without the assistance of medical professionals. The company's products include PainShield® and WoundShield™, which both have CE Mark. The PainShield™ also has FDA clearance. NanoVibronix's catheter based products include the UroShield™ and NG-Shield™ that are both CE Marked.
NanoViricides, Inc. (NYSE MKT: NNVC) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H5N1 bird flu, seasonal influenza, HIV, EKC, hepatitis C, rabies, dengue fever, and Ebola virus, among others.
Nokia Corp. (NYSE:NOK) manufactures and sells mobile devices, and provides Internet and digital mapping and navigation services worldwide. Nano: Nano Battery Backup Unit maintains a small cell's operation should its power supply fail, which is a mandatory requirement in some markets.
Novavax Inc. (NasdaqGS: NVAX) is a clinical-stage biopharmaceutical company creating vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide. Using innovative proprietary recombinant nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases.
NVE Corp (NasdaqCM:NVEC) is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. NVE has also licensed its spintronic magnetoresistive random access memory technology, commonly known as MRAM.
Oasmia Pharmaceutical AB (NasdaqCM:OASM; Stockholm:OASM.ST) develops, manufactures, markets and sells new generations of drugs in the field of human and veterinary oncology. The company's product development aims to create and manufacture novel nanoparticle formulations and drug-delivery systems based on well-established cytostatics which, in comparison with current alternatives, show improved properties, reduced side-effects, and expanded applications. The company's product development is based on its proprietary in-house research and company patents.
Obducat (Frankfurt:OBD.F) business concept is to develop and supply lithography solutions for production and replication of advanced micro and nanostructures for industrial needs, as well as for R&D. Sales includes systems for lithography processing, imprint molds, consumables and licenses.
Oxford Instruments PLC (LSE:OXIG.L) is a provider of technology tools and systems for industry and research. The Company operates through three segments: Nanotechnology Tools, Industrial Products and Service. The Nanotechnology Tools segment offers technology products serving research customers in both the public and private sectors. The Industrial Products segment contains a group of businesses supplying technology products and components manufactured in medium volume for industrial customers. The Service segment contains the Company's service, rental and refurbished asset sales business. Its NanoAnalysis business delivers solutions and services that enable materials characterization and sample manipulation at the nano scale. Its products are used on electron microscopes and ion-beam systems in academic institutions and industrial applications, including semi-conductors, renewable energy, mining, metallurgy and forensics. Its products include AZtecOne and X-Max Extreme detector, among others.
Pacific Biosciences (NasdaqGS:PACB) offers sequencing systems to help scientists resolve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT®) Technology, Pacific Biosciences' products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Pacific Biosciences' technology provides high accuracy, ultra-long reads, uniform coverage, and is the only DNA sequencing technology that provides the ability to simultaneously detect epigenetic changes. PacBio® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT Sequencing - Harnessing advances in biochemistry, optics, nanofabrication, and more.
PEN Inc. (OTC:PENC) is a global leader in developing, commercializing, and marketing consumer and industrial products enabled by nanotechnology that solve everyday problems for customers in the optical, transportation, military, sports, and safety industries. Through PEN's wholly-owned subsidiary Nanofilm Ltd., the Company develops, manufactures and sells products based on nanotechnology including the ULTRA CLARITY® brand eyeglass cleaner, CLARITY DEFOG IT™ brand defogging products and CLARITY ULTRASEAL® nanocoating products for glass and ceramics. The Company also sells the environmentally friendly HALO™ brand surface protector, fortifier, and cleaner through a wholly-owned subsidiary, PEN Technology, LLC. The Company's Applied Nanotech, Inc. subsidiary in Austin, Texas functions as the Design Center conducting research and development services for government and private customers and new product development for PEN focusing on innovative and advanced product solutions in the areas of safety, health, and sustainability.
PHI Group Inc. (OTC:PHIL) primarily focuses on acquisitions as a principal and invests in energy, natural resources and special situations that may substantially enhance shareholder value. In addition, the Company also provides merger and acquisition advisory services through its wholly owned subsidiary PHI Capital Holdings, Inc. and earns revenues in forms of cash and equity for services rendered. Nanotech – January 2017: signed an agreement with Nhat Hai New Technology JSC, a Vietnam-based company specializing in applied research and nanotechnologies (http://www.nanotechnology.com.vn), to form a joint venture company in the United States to apply the latter's nanotechnologies for the production of various nano products.
Pivot Pharmaceuticals Inc. (CSE: PVOT; OTCQB: PVOTF) is an emerging biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot's wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. ("PGS" or "Pivot Green Stream"), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. PGS has acquired worldwide rights to BiPhasix™ Transdermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral) and Thrudermic Transdermal Nanotechnology (transdermal) for the delivery and commercialization of cannabinoid, cannabidiol (CBD), and tetrahydrocannabinol (THC)-based products. PGS' initial product development candidates will include topical treatments for women's sexual dysfunction (PGS-N005), as well as psoriasis (PGS-N007), and an oral product (PGS-N001) for cancer supportive care.
Plus Therapeutics, Inc. (NasdaqCM:PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets. Central to the Company's drug development is a unique nanotechnology platform designed to reformulate, deliver and commercialize multiple drugs targeting rare cancers and other diseases. The platform is designed to facilitate new delivery approaches and/or formulations of safe and effective, injectable drugs, potentially enhancing the safety, efficacy and convenience for patients and healthcare providers.
pSivida Ltd. (NasdaqGM:PSDC) is a leader in the development of sustained release drug for eye diseases. pSivida has developed three of only four FDA-approved sustained-release treatments for back-of-the-eye diseases. The most recent, ILUVIEN®, a micro-insert for diabetic macular edema, licensed to Alimera Sciences, is currently sold in the US and three EU countries. Retisert®, an implant for posterior uveitis, is licensed to and sold by Bausch & Lomb. pSivida's lead product candidate, Durasert micro-insert for posterior segment uveitis being independently developed, is currently in pivotal Phase 3 clinical trials. pSivida's pre-clinical development program is focused on using its core platform technologies Durasert™ and Tethadur™, a nanostructured bioerodible material, to deliver drugs and biologics to treat uveitis, wet and dry age-related macular degeneration, osteoarthritis and other diseases.
Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) is a clinical stage biopharmaceutical company dedicated to developing best-in-class therapeutics for the treatment of cancer. Rexahn currently has three clinical stage oncology candidates, Archexin®, RX-3117, and Supinoxin™ (RX-5902) and a robust pipeline of preclinical compounds to treat multiple types of cancer. Rexahn has also developed proprietary drug discovery platform technologies in the areas of Nano-Polymer-Drug Conjugate Systems (NPDCS), CPMA, 3D-GOLD, and TIMES.
Sixth Wave Innovations Inc. (CSE:SIXW) is a nanotechnology company focused on extraction and detection of target substances at the molecular level. The company's products provide significant advantages in cost and performance. These advantages are derived from application of the company's patented technologies in the highly specialized field of molecularly imprinted polymers (MIPs). Sixth Wave is commercializing IXOS®, a line of extraction polymers for the gold mining industry and Affinity™ for the Cannabis Industry.
Sona Nanotech Inc. (CSE: SONA; OTC:SNANF) is a nanotechnology life sciences firm that has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles. The principal business carried out and intended to be continued by Sona is the development and application of its proprietary technology for use in multiplex diagnostic testing platforms that will improve performance over existing tests in the market. Sona's gold nanorod particles are CTAB (cetyltrimethylammonium) free, eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. It is expected that Sona's gold nanotechnologies may be adapted for use in applications, as a safe and effective delivery system for multiple medical treatments, pending the approval of various regulatory boards including Health Canada and the FDA.
Sono-Tek Corporation (OTC:SOTK) is a leading developer and manufacturer of liquid spray products based on its proprietary ultrasonic nozzle technology. Founded in 1975, the Company's products have long been recognized for their performance, quality, and reliability. We create patented high performance ultrasonic spray coating technology used in manufacturing precision electronics, fuel cells, solar cells, medical devices, float and panel glass, nanotechnology coatings and other industrial applications.
Starpharma Holdings Ltd. (ASX:SPL.AX) is an ASX 300 company and is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications. Starpharma's underlying technology is built around dendrimers - a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical and medical uses. Starpharma has three core development programs: VivaGel® portfolio, drug delivery, and agrochemicals with the Company developing a number of products internally and others via commercial partnerships. Starpharma's lead products are based on VivaGel® (SPL7013, astodrimer sodium), a proprietary dendrimer which is a potent microbicidal agent. VivaGel®, formulated as a water based gel and delivered vaginally is under clinical development for the management and prevention of bacterial vaginosis (BV). Starpharma has also signed separate licence agreements with Ansell Limited (ASX:ANN) and Okamoto Industries. Inc., (TSE: JP3192800005) to market a value-added VivaGel® condom. Okamoto is the market leader for condoms sold in Japan, which is the world's second largest condom market. Ansell manufactures and sells leading condom brands worldwide, including LifeStyles®, ZERO® and SKYN®. In the wider pharmaceutical and life science fields, Starpharma has both partnered and internal programs in Drug Delivery. Drug Delivery partners include GSK, Lilly and AstraZeneca. A number of dendrimer-enhanced, or DEP™ versions of existing drugs are under development. The most advanced of these is DEP™ docetaxel, a dendrimer-enhanced version of docetaxel (Taxotere®), which is in clinical development. In preclinical studies DEP™ docetaxel has shown significant tumour-targeting and superior anti-cancer effects across a range of important cancer types including breast, prostate, lung and ovarian tumour, when compared to Taxotere® (docetaxel).
STMicroelectronics (NYSE:STM) is a global semiconductor leader delivering intelligent and energy-efficient products and solutions that power the electronics at the heart of everyday life. ST's products are found everywhere today, and together with our customers, we are enabling smarter driving and smarter factories, cities and homes, along with the next generation of mobile and Internet of Things devices. By getting more from technology to get more from life, ST stands for life.augmented. Nano Accelerometer
Tekmira Pharmaceuticals Corporation (TSX:TKM.TO; NasdaqCM:TKMR) is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle (LNP) delivery technology to pharmaceutical and biotechnology partners. Tekmira has been working in the field of nucleic acid delivery for over a decade, and has broad intellectual property covering its delivery technology.
Ultratech, Inc.(NasdaqGS:UTEK) develops, manufactures and markets photolithography, laser thermal processing and inspection equipment. The Company operates through the manufacture and distribution of capital equipment to manufacturers of integrated circuits and nanotechnology components segment. The Company serves manufacturers of semiconductor devices, including advanced packaging processes and various nanotechnology components, such as thin film head magnetic recording devices (thin film heads or TFHs), laser diodes, high-brightness light emitting diodes (HBLEDs), as well as atomic layer deposition systems (ALD).
Veeco Instruments Inc. (NasdaqGS:VECO) process equipment solutions enable the manufacture of LEDs, displays, power electronics, compound semiconductors, hard disk drives, semiconductors, MEMS and wireless chips. We are the leader in MOCVD, MBE, Ion Beam, Wet Etch single wafer processing and other advanced thin film process technologies. Our high performance systems drive innovation in energy efficiency, consumer electronics and network storage and allow our customers to maximize productivity and achieve lower cost of ownership Nano
Zecotek Photonics Inc. (TSX:ZMS.V) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners such as the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), and National NanoFab Center (South Korea).
Russia Joint Ventures:
RUSNANO Corporation implements state policy for the development of the nanoindustry in Russia, acting as a co-investor in nanotechnology projects, which have substantial economic or social potential. Current Companies: With financial support from RUSNANO, project companies inaugurated more than 20 new manufacturing facilities. Employees in these factories use nanotechnologies to produce a range of goods: from 90-nm integrated circuits to ultrastrength springs for, in part, railway transport.
Our site does not give specific recommendations and encourages investors to complete their own due diligence. Our lists are compiled from internal and external research sources. Our lists are to be used only as a partial source of due diligence.